Previous Close | 82.20 |
Open | 83.01 |
Bid | 79.66 x 800 |
Ask | 80.45 x 1200 |
Day's Range | 79.00 - 84.34 |
52 Week Range | 19.51 - 92.60 |
Volume | 1,061,886 |
Avg. Volume | 891,696 |
Market Cap | 8.268B |
Beta (5Y Monthly) | 1.40 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.00 |
Earnings Date | May 05, 2021 - May 10, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 92.42 |
Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here. During the fourth quarter of 2020, the Baron Health Care Fund returned 17.1% (institutional shares). In comparison, the benchmark S&P 500 Index was up 12.15%, while the Russell 3000 Health Care Index was up 10.08%. You should […]
A look at the shareholders of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. Companies that used to be publicly owned tend to have lower insider ownership.
By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Multiple Catalysts in 2021 Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) is developing medicines that cause gene silencing using RNA interference (RNAi), a specific means of inhibiting the expression of genes and stopping the production of a specific protein. The company has a deep and diverse pipeline consisting of